Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × ABVD protocol × Clear all

Phase

Status

Terminated 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

Cisplatin 305 Capecitabine 220 Oxaliplatin 219 Radiotherapy 206 Docetaxel 193 Carboplatin 188 Cyclophosphamide 186 Gemcitabine 185 apatinib 182 Drug Therapy 173 Paclitaxel 172 Fluorouracil 160 camrelizumab 159 Bevacizumab 157 Blood Specimen Collection 112 Irinotecan 106 sintilimab 105 Dexamethasone 102 Etoposide 101 toripalimab 95 Surgical Procedures, Operative 94 Radiosurgery 94 Pemetrexed 91 pembrolizumab 89 S 1 (combination) 89 anlotinib 85 Leucovorin 85 Surveys and Questionnaires 83 Rituximab 83 Nivolumab 83

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00736320 2020-11-04

HD16

University of Cologne

Phase 3 Unknown

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡